Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Wow! IIROC

<< Previous

Bullboard Posts

Next >>

Comment by Redbaron2211on Dec 12, 2020 9:12am

159 Views

Post# 32092717

RE:RE:RE:RE:RE:RE:RE:Wow! IIROC

Elign I agree Sigilon valuation is the main driver but the release of Philips interview was timed well. It put gas on the pedal with him speaking on a collaboration deal. It's nice to see the dots being connected we need more of this.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing